Spector D H, Baltimore D
J Virol. 1975 Jun;15(6):1418-31. doi: 10.1128/JVI.15.6.1418-1431.1975.
The content, size, and mechanism of synthesis of 3'-terminal poly(A) on the various intracellular species of poliovirus RNA have been examined. All viral RNA species bound to poly(U) filters and contained RNase-resistant stretches of poly(A) which could be analyzed by electrophoresis in polyacrylamide gels. At 3 h after infection, the poly(A) on virion RNA, relicative intermediate RNA, polyribosomal RNA, and total cytoplasmic 35S RNA was heterogeneous in size with an average length of 75 nucleotides. By 6 h after infection many of the intracellular RNA's had poly(A) of over 150 nucleotides in length, but the poly(A) in virion RNA did not increase in size suggesting that the amount of poly(A) which can be encapsidated is limited. At all times, the double-stranded poliovirus RNA molecules had poly(A) of 150 to 200 nucleotides. Investigation of the kinetics of poly(A) appearance in the replicative intermediate and in finished 35S molecules indicated that poly(A) is the last portion of the 35S RNA to be synthesized; no nascent poly(A) could be detected in the replicative intermediate. Although this result indicates that poliovirus RNA is synthesized 5' leads to 3' like other RNA's, it also suggests that much of the poly(A) found in the replicative intermediate is an artifact possibly arising from the binding of finished 35S RNA molecules to the replicative intermediate during extraction. The addition of poly(A) to 35S RNA molecules was not sensitive to guanidene.
对脊髓灰质炎病毒RNA的各种细胞内种类上3'-末端多聚腺苷酸(poly(A))的含量、大小及合成机制进行了研究。所有病毒RNA种类均能与聚尿嘧啶(poly(U))滤膜结合,并含有对核糖核酸酶(RNase)有抗性的多聚腺苷酸片段,这些片段可通过聚丙烯酰胺凝胶电泳进行分析。感染后3小时,病毒粒子RNA、复制中间体RNA、多核糖体RNA和总细胞质35S RNA上的多聚腺苷酸大小不均一,平均长度为75个核苷酸。感染后6小时,许多细胞内RNA的多聚腺苷酸长度超过150个核苷酸,但病毒粒子RNA中的多聚腺苷酸大小并未增加,这表明能够被包装的多聚腺苷酸量是有限的。在所有时间点,脊髓灰质炎病毒双链RNA分子的多聚腺苷酸长度为150至200个核苷酸。对多聚腺苷酸在复制中间体和完整35S分子中出现的动力学研究表明,多聚腺苷酸是35S RNA中最后合成的部分;在复制中间体中未检测到新生的多聚腺苷酸。尽管这一结果表明脊髓灰质炎病毒RNA像其他RNA一样是从5'端向3'端合成的,但也表明在复制中间体中发现的许多多聚腺苷酸可能是一种假象,可能是在提取过程中完整的35S RNA分子与复制中间体结合产生的。向35S RNA分子添加多聚腺苷酸对胍不敏感。